Services

Clinical Phase API - Overview

Pharma Solutions has been working with pharma companies for Clinical Phase API services for over  30 years. The group has a number of process development labs, kilo labs and pilot plants  across a network of sites in North America, UK and India. The group works with a number of biotech/virtual pharma companies to supply  API from preclinical/Phase I studies to commercial launch and is uniquely positioned to integrate services across geographies to give customers greater reliability, cost competitiveness and speed

• Our Torcan (Toronto) site (erstwhile Torcan) in North America and Morpeth & Huddersfield sites in UK specialize in synthesis of APIs at Kilogram scale for early evaluations and are also supported by full range of material characterization studies
• Our Chennai site has been recently expanded for scale up equipment and is a key site for advanced intermediates and API synthesis
• Our Grangemouth site in UK is engaged in supply of cytotoxic APIs with special focus on supply of early phase Monoclonal Antibodies and cytotoxic API conjugates